1. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Issue 10367 (3rd December 2022) Authors: Schlaich, Markus P; Bellet, Marc; Weber, Michael A; Danaietash, Parisa; Bakris, George L; Flack, John M; Dreier, Roland F; Sassi-Sayadi, Mouna; Haskell, Lloyd P; Narkiewicz, Krzysztof; Wang, Ji-Guang; Reid, Christopher; Schlaich, Markus; Katz, Ivor; Ajani, Andrew; Biswas, Sinjini; Esler, Murray; ... Journal: Lancet Issue: Volume 400:Issue 10367(2022) Page Start: 1927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) in adults receiving hemodialysis. Issue 25 (8th June 2021) Authors: Awad, Ahmed M.; Ntoso, Adu; Connaire, Jeffrey J.; Hernandez, German T.; Dhillon, Kiranjit; Rich, Lisa; Henderson, Heather; Lynn, Robert; Hyer, Randall N.; Xie, Fang; Erby, Kimberly; Janssen, Robert S. Journal: Vaccine Issue: Volume 39:Issue 25(2021) Page Start: 3346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of adding milk to black tea on vascular function in healthy men and women: a randomised controlled crossover trial. Issue 12 (9th November 2018) Authors: Ahmad, Adilah F.; Rich, Lisa; Koch, Henrietta; Croft, Kevin D.; Ferruzzi, Mario G.; Kay, Colin D.; Hodgson, Jonathan M.; Ward, Natalie C. Journal: Food & function Issue: Volume 9:Issue 12(2018) Page Start: 6307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗